Edoardo Missiglia
YOU?
Author Swipe
View article: Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient Open
The treatment of BRAFV600E mutant melanoma has been revolutionized by BRAF inhibitors. Furthermore, the BRAF/MEK combination has shown further improvement in clinical outcomes in advanced and in adjuvant melanoma patients. In low-grade ova…
View article: MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT Open
Introduction: Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive primary intestinal T-cell lymphoma. Most case series were reported in Asia. Here we present a detailed clinico-pathological analysis of a Eur…